SOLARAZE gel 3 % tb 25 g
7680605800057
CH-60580
D11AX18
10.99.0.
1 / 3
google
Details
- Product number
- 6058001
- CPT
- -
- Packaging group
- 25
- Unit
- g
- Composition
- diclofenacum natricum 30 mg, macrogoli 350 aether methylicus, natrii hyaluronas, aqua purificata, alcohol benzylicus 10 mg, ad gelatum pro 1 g.
Articles (1)
Solaraze 3%, Gel
Gel
25
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
30.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
10.0 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 33.25
Specialties list
Yes
Generic
No
SL addition date:
01/05/2011
Authorization holder
Almirall AG
8304 Wallisellen
Authorization information
- Swissmedic authorization number
- 60580
- Drug name
- Solaraze 3%, Gel
- Galenic form
- GELK
- ATC Code
- D11AX18
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 23/12/2010
- Authorization expiration date
- 31/12/9999
- IT number
- 10.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SOLARAZE gel 3 % tb 25 g
- Description (DE)
- SOLARAZE Gel 3 % Tb 25 g
- Market launch
- 23/12/2010
- Narcotic (BTM)
- No